PMID- 11389049 OWN - NLM STAT- MEDLINE DCOM- 20010621 LR - 20071114 IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 61 IP - 11 DP - 2001 Jun 1 TI - Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. PG - 4306-10 AB - Retinoids are essential for normal skin growth, differentiation, and apoptosis and are active pharmacologically in the prevention and treatment of skin cancers and other lesions. Retinoid effects are mediated mainly by retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which act as transcription factors to alter gene expression. Using in situ hybridization, we analyzed the expression of RARs and RXRs in normal sun-exposed skin (n = 85), squamous cell carcinoma (SCC; n = 28), and actinic keratosis [AK (a precursor to SCC); n = 38]. The expressions of five receptors (RAR-alpha and -gamma and RXR-alpha, -beta, and -gamma) were moderate to very strong in normal skin, with higher expressions in spinous and granular layers than in the basal layer. RAR-beta expression was weak or absent in normal and lesion samples. All five receptors expressed in the skin were suppressed progressively from normal skin to premalignant skin (AK) to invasive skin SCC. Specific receptor decreases in lesions relative to normal skin ranged from 75% (RXR-beta) to 96% (RAR-alpha) in SCC and from 37% (RAR-gamma) to 68% (RXR-beta) in AK. The degree of suppression of RXR-alpha and RAR-gamma, the two predominant retinoid receptors in skin, was relatively less for RXR-alpha (58% versus 86%; P = 0.015) and relatively greater for RAR-gamma (37% versus 89%; P = 0.0001) between AK and SCC, suggesting that suppression of RXR-alpha may be an earlier event and expression of RAR-gamma may be a later event of multistep squamous skin carcinogenesis. Our results indicate that suppressed expression of retinoid receptors occurs early (in AK) and is associated with progression of squamous skin carcinogenesis to SCC. FAU - Xu, X C AU - Xu XC AD - Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. FAU - Wong, W Y AU - Wong WY FAU - Goldberg, L AU - Goldberg L FAU - Baer, S C AU - Baer SC FAU - Wolf, J E AU - Wolf JE FAU - Ramsdell, W M AU - Ramsdell WM FAU - Alberts, D S AU - Alberts DS FAU - Lippman, S M AU - Lippman SM FAU - Lotan, R AU - Lotan R LA - eng GR - 2P01 CA27502/CA/NCI NIH HHS/United States GR - 5P01 CA68233/CA/NCI NIH HHS/United States GR - CA16672/CA/NCI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (Receptors, Retinoic Acid) SB - IM MH - Aged MH - Aged, 80 and over MH - Carcinoma, Basal Cell/metabolism MH - Carcinoma, Squamous Cell/*metabolism MH - Humans MH - In Situ Hybridization MH - Keratosis/metabolism MH - Middle Aged MH - Precancerous Conditions/metabolism MH - Receptors, Retinoic Acid/*biosynthesis/classification MH - Skin/*metabolism MH - Skin Neoplasms/*metabolism EDAT- 2001/06/05 10:00 MHDA- 2001/06/22 10:01 CRDT- 2001/06/05 10:00 PHST- 2001/06/05 10:00 [pubmed] PHST- 2001/06/22 10:01 [medline] PHST- 2001/06/05 10:00 [entrez] PST - ppublish SO - Cancer Res. 2001 Jun 1;61(11):4306-10.